Home » Topics » BioWorld Science

BioWorld Science
RSS

Bragsin inhibits BRAG2-mediated Arf GTPase activation in vitro in a membrane-dependent manner

May 3, 2019

3-V Biosciences initiates phase II trial of TVB-2640 in NASH

May 2, 2019

FDA issues complete response letter for Contepo for complicated urinary tract infections

May 2, 2019

Kalydeco approved in U.S. for infants from 6 months with cystic fibrosis

May 2, 2019

Phase I study of CVN-424 for Parkinson's demonstrates safety in healthy subjects

May 2, 2019

European Commission approves Skyrizi for plaque psoriasis

May 2, 2019

FDA approves Mavyret for pediatric patients with HCV

May 2, 2019

Checkpoint Therapeutics reports interim data from phase I trial of cosibelimab

May 2, 2019

FDA issues complete response letter for HTX-011 for postoperative pain

May 2, 2019

Genkyotex reports topline phase II data for GKT-831 in primary biliary cholangitis

May 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...